Login

Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell. 00:10:00

Share On Facebook Share On Twitter

Martin J Schroeter is Chairman/CEO at Kyndryl Holdings Inc. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jonathan Satchell, CEO of Learning Technologies Group PLC, anticipates strong full-year revenue and earnings in an interview with Proactive's Andrew Scott.
00:10:00
Recently, Liu Chunhe, CEO of Newborn Town, discussed business developments without further details provided in the text.
00:10:00
Diversity and Inclusion: O'Melveny's Action Plan | Darin Snyder - Partner, O'Melveny & Myers LLP
00:10:00
Efficient Document Management Boosts Productivity at Valeo Financial Advisors | Jhon Trott , Founder , Valeo Financial Advisors.
00:10:00
"The Power of Regular Contributions and Early Savings: Sergio Fernández-Pacheco Explores MiFID II's Impact on Investment Strategies"
00:10:00
Peak Resources: Pioneering Rare Earths in Tanzania for Sustainable Battery Solutions
00:10:00
Setting Financial Goals with Expert Guidance: Insights from ICF Coach Sarah Fincher | Michelle Smalenberger, CEO, Financial Design Studio.
00:10:00
Bill Demchak's Economic Outlook: Market Resilience Amid Uncertainty | Bill Demchak, CEO, PNC Financial Services .
00:00:00
Symptoms After Valve Replacement - Dr Mario Garcia Gomez , Mayo Clinic
00:10:00
Impact of Energy Transition on Metals & Mining Markets: Opportunities and Strategies
00:10:00
Navigating Divorce or Loss: Practical Tips for Managing Financial Tasks
00:10:00
Hartford CEO Christopher Swift on Hawaii, Extreme Weather, and Insurance Market Trends | Christopher J. Swift, CEO , The Hartford.

© 2017 - Neuhu+